Bludigo (indigotindisulfonate sodium)
Intravenous Ampul (ML)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Indigotindisulfonate sodium is a dye.
Indigotindisulfonate sodium was originally used as an index of renal function. Because excretion of the dye does not correlate with renal function, its use for that purpose has largely been replaced by other agents that yield more precise results.
Generic name: indigotindisulfonate sodium
Therapeutic class: Diagnostic Agents
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Bludigo
Indications
No indications are available for this drug.
Dosing
Indigotindisulfonate sodium may be administered by IM or, preferably, IV injection.
The usual dose of indigotindisulfonate sodium is 40 mg. Larger doses may be required when the drug is given IM. Smaller doses may be desirable in infants, children, and underweight patients to prevent skin discoloration. (See Cautions: Adverse Effects.) Appearance of the dye at the ureteral orifices is observed with the cystoscope in place.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
Rare or Very Rare
- Hypertension
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
Animal reproduction studies have not been performed with indigotindisulfonate sodium, and it is also not known whether the drug can cause fetal harm when administered to pregnant women. Indigotindisulfonate sodium should be used during pregnancy only when clearly needed.
Since it is not known whether indigotindisulfonate sodium is distributed into human milk, the drug should be used with caution in nursing women.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.